An area of ongoing research is the cascading effect taking a GLP-1 can have on the body
In the U.S., suppliers must comply with FDA Good Manufacturing Practices (GMP), and products should carry a GRAS (Generally Recognized As Safe) designation if marketed as dietary supplements
And this was an extraordinarily important push because what it has resulted in, of course, has been spectacular
[3][6] NLEM 2022 already emphasises the growing burden of diabetes and the need for key diabetes drugs in public systems, and official documents acknowledge GLP-1 RAs as important options.[15] If liraglutide and semaglutide formulations used for diabetes are eventually brought under price control, MRPs could drop by another 2030% beyond current generic competition, especially where innovator prices remain high
Nature 490 , 508513 (2012) Yang, L
In SURMOUNT-3, 600 participants are randomized to receive either tirzepatide at the maximally tolerated dose or placebo following a structured intensive 12-week lifestyle intervention
